Format

Send to

Choose Destination
J Invest Dermatol. 2014 Dec;134(12):3000-3003. doi: 10.1038/jid.2014.272. Epub 2014 Jul 7.

Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclass.

Author information

1
Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
2
Department of Clinical Pathology, Skåne University Hospital, Lund, Sweden.
3
Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Clinical Pathology, Skåne University Hospital, Lund, Sweden.
4
Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
5
Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
6
QIMR Berghofer Medical Research Institute, Brisbane, Australia.
7
Department of Dermatology, LUMC, Leiden, The Netherlands.
8
Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Electronic address: goran_b.jonsson@med.lu.se.
PMID:
24999598
DOI:
10.1038/jid.2014.272
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center